Live Breaking News & Updates on Clinical Research Center School
Stay updated with breaking news from Clinical research center school. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The results of pooled safety data for Adbry showed positive effects in the prolonged treatment of moderate to severe atopic dermatitis, according to a study. Adbry (tralokinumab, LEO Pharma) is the only FDA-approved biologic that specifically binds to and inhibits the interleukin (IL)-13 cytokine, one of the drivers of atopic dermatitis. ....